Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2022

Dec 5, 2022

33003_dirs_2022-12-05_dfe3abeb-6508-43d9-ad4f-10c5e77bc654.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-12-02

Reporting Person: Howton David T (See Remarks)